Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Input of recombinant phenotyping for the characterization of a novel acyclovir-resistance mutation identified in a patient with recurrent herpetic keratitis.

Robinet-Perrin A, Tumiotto C, Cornut T, Santoni A, Touboul D, Goupil-Gouyette T, Garrigue I, Boutolleau D, Burrel S.

Antiviral Res. 2019 Aug;168:183-186. doi: 10.1016/j.antiviral.2019.06.007. Epub 2019 Jun 11.

PMID:
31199933
2.

Added value of ultra-deep sequencing (UDS) approach for detection of genotypic antiviral resistance of herpes simplex virus (HSV).

Mercier-Darty M, Boutolleau D, Rodriguez C, Burrel S.

Antiviral Res. 2019 Aug;168:128-133. doi: 10.1016/j.antiviral.2019.05.017. Epub 2019 May 31.

PMID:
31158412
3.

Multirecombinant Enterovirus A71 Subgenogroup C1 Isolates Associated with Neurologic Disease, France, 2016-2017.

Ngangas ST, Lukashev A, Jugie G, Ivanova O, Mansuy JM, Mengelle C, Izopet J, L'honneur AS, Rozenberg F, Leyssene D, Hecquet D, Marque-Juillet S, Boutolleau D, Burrel S, Peigue-Lafeuille H, Archimbaud C, Benschop K, Henquell C, Mirand A, Bailly JL.

Emerg Infect Dis. 2019 Jun;25(6):1204-1208. doi: 10.3201/eid2506.181460.

4.

Antiviral effects of Cacicol®, a heparan sulfate biomimetic for corneal regeneration therapy, for herpes simplex virus type-1 and varicella zoster virus infection.

Deback C, Rousseau A, Breckler M, Molet L, Boutolleau D, Burrel S, Roque-Afonso AM, Labetoulle M.

Antivir Ther. 2018;23(8):665-675. doi: 10.3851/IMP3254.

PMID:
30028308
5.

Utility of ultra-deep sequencing for detection of varicella-zoster virus antiviral resistance mutations.

Mercier-Darty M, Boutolleau D, Lepeule R, Rodriguez C, Burrel S.

Antiviral Res. 2018 Mar;151:20-23. doi: 10.1016/j.antiviral.2018.01.008. Epub 2018 Jan 12.

PMID:
29337163
6.

A European multi-centre External Quality Assessment (EQA) study on phenotypic and genotypic methods used for Herpes Simplex Virus (HSV) drug resistance testing.

Afshar B, Bibby DF, Piorkowska R, Ohemeng-Kumi N, Snoeck R, Andrei G, Gillemot S, Morfin F, Frobert E, Burrel S, Boutolleau D, Crowley B, Mbisa JL.

J Clin Virol. 2017 Nov;96:89-93. doi: 10.1016/j.jcv.2017.10.002. Epub 2017 Oct 6.

PMID:
29031157
7.

Recurrent herpetic keratitis despite antiviral prophylaxis: A virological and pharmacological study.

Rousseau A, Boutolleau D, Titier K, Bourcier T, Chiquet C, Weber M, Colin J, Gueudry J, M'Garrech M, Bodaghi B, Burrel S, Agut H, Deback C; HEDGOF (Herpes Eye Disease Group of France), Labetoulle M.

Antiviral Res. 2017 Oct;146:205-212. doi: 10.1016/j.antiviral.2017.09.013. Epub 2017 Sep 20.

PMID:
28939476
8.

Epstein-Barr Virus-related Acute Genital Ulcer Successfully Treated with Colchicine.

Nouchi A, Monsel G, Lafon-Desmurs B, Meng L, Burrel S, Moyal-Barracco M, Caumes E.

Acta Derm Venereol. 2018 Jan 12;98(1):134-135. doi: 10.2340/00015555-2761. No abstract available.

9.

Ancient Recombination Events between Human Herpes Simplex Viruses.

Burrel S, Boutolleau D, Ryu D, Agut H, Merkel K, Leendertz FH, Calvignac-Spencer S.

Mol Biol Evol. 2017 Jul 1;34(7):1713-1721. doi: 10.1093/molbev/msx113.

10.

Où en est la recherche sur les antiviraux ?

Agut H, Burrel S, Bonnafous P, Boutolleau D.

Rev Prat. 2016 Nov;66(9):1007-1014. French.

PMID:
30512372
11.

Herpes simplex virus type 2: Cluster of unrelated cases in an intensive care unit.

Troché G, Marque Juillet S, Burrel S, Boutolleau D, Bédos JP, Legriel S.

Am J Infect Control. 2016 Oct 1;44(10):1178-1180. doi: 10.1016/j.ajic.2016.03.035. Epub 2016 May 16.

PMID:
27198455
12.

Complementary assays for monitoring susceptibility of varicella-zoster virus resistance to antivirals.

Perrier M, Désiré N, Deback C, Agut H, Boutolleau D, Burrel S.

J Virol Methods. 2016 Jul;233:10-4. doi: 10.1016/j.jviromet.2016.03.006. Epub 2016 Mar 16.

PMID:
26994966
13.

High conservation of herpes simplex virus UL5/UL52 helicase-primase complex in the era of new antiviral therapies.

Collot M, Rouard C, Brunet C, Agut H, Boutolleau D, Burrel S.

Antiviral Res. 2016 Apr;128:1-6. doi: 10.1016/j.antiviral.2016.01.015. Epub 2016 Jan 28.

PMID:
26826441
14.

Tenofovir Gel to Prevent HSV-2 Infection.

Agut H, Burrel S, Boutolleau D.

N Engl J Med. 2015 Nov 12;373(20):1980. doi: 10.1056/NEJMc1511338. No abstract available.

PMID:
26559586
15.

Genetic Diversity within Alphaherpesviruses: Characterization of a Novel Variant of Herpes Simplex Virus 2.

Burrel S, Désiré N, Marlet J, Dacheux L, Seang S, Caumes E, Bourhy H, Agut H, Boutolleau D.

J Virol. 2015 Dec;89(24):12273-83. doi: 10.1128/JVI.01959-15. Epub 2015 Sep 23.

16.

Management of multidrug-resistant CMV infection in immunocompromised patients: case report of a heart-transplant recipient and review of the literature.

Deback C, Burrel S, Varnous S, Carcelain G, Conan F, Aït-Arkoub Z, Autran B, Gandjbakhch I, Agut H, Boutolleau D.

Antivir Ther. 2015;20(2):249-54. doi: 10.3851/IMP2818. Epub 2014 Jun 25. Review.

PMID:
25219330
17.

Resistance of herpes simplex viruses to acyclovir: an update from a ten-year survey in France.

Frobert E, Burrel S, Ducastelle-Lepretre S, Billaud G, Ader F, Casalegno JS, Nave V, Boutolleau D, Michallet M, Lina B, Morfin F.

Antiviral Res. 2014 Nov;111:36-41. doi: 10.1016/j.antiviral.2014.08.013. Epub 2014 Sep 8.

PMID:
25218782
18.

Human cytomegalovirus (CMV) susceptibility to currently approved antiviral drugs does not impact on CMV terminase complex polymorphism.

Pilorgé L, Burrel S, Aït-Arkoub Z, Agut H, Boutolleau D.

Antiviral Res. 2014 Nov;111:8-12. doi: 10.1016/j.antiviral.2014.08.014. Epub 2014 Sep 4.

PMID:
25194992
19.

Impact of HIV-1 infection on herpes simplex virus type 2 genetic variability among co-infected individuals.

Abrão EP, Burrel S, Désiré N, Bonnafous P, Godet A, Caumes E, Agut H, Boutolleau D.

J Med Virol. 2015 Mar;87(3):357-65. doi: 10.1002/jmv.24061. Epub 2014 Sep 1.

PMID:
25174847
20.

Helicase-primase inhibitor pritelivir for HSV-2 infection.

Burrel S, Rouard C, Boutolleau D.

N Engl J Med. 2014 Apr 24;370(17):1663-4. doi: 10.1056/NEJMc1402071. No abstract available.

PMID:
24758629
21.

Long-term follow-up of HIV-infected patients once diagnosed with acyclovir-resistant herpes simplex virus infection.

Seang S, Boutolleau D, Burrel S, Regnier S, Epelboin L, Voujon D, Valantin MA, Katlama C, Agut H, Caumes E.

Int J STD AIDS. 2014 Aug;25(9):676-82. doi: 10.1177/0956462413518034. Epub 2014 Feb 17.

PMID:
24535691
22.

Validation of the QIAsymphony RGQ system for DNA quantitation of different BK virus genotypes in whole blood samples.

Burrel S, Brunet C, Hamm N, Gits-Muselli M, Hermet L, Aimé C, Agut H, Boutolleau D.

J Virol Methods. 2014 Feb;196:32-5. doi: 10.1016/j.jviromet.2013.10.030. Epub 2013 Oct 30.

PMID:
24184087
23.

Surveillance of herpes simplex virus resistance to antivirals: a 4-year survey.

Burrel S, Aime C, Hermet L, Ait-Arkoub Z, Agut H, Boutolleau D.

Antiviral Res. 2013 Nov;100(2):365-72. doi: 10.1016/j.antiviral.2013.09.012. Epub 2013 Sep 25.

PMID:
24075863
24.

Molecular characterization of herpes simplex virus 2 strains by analysis of microsatellite polymorphism.

Burrel S, Ait-Arkoub Z, Voujon D, Deback C, Abrao EP, Agut H, Boutolleau D.

J Clin Microbiol. 2013 Nov;51(11):3616-23. doi: 10.1128/JCM.01714-13. Epub 2013 Aug 21.

25.

Acyclovir-resistant varicella-zoster virus keratitis in an immunocompetent patient.

Gueudry J, Boutolleau D, Gueudin M, Burrel S, Miri A, Bodaghi B, Muraine M.

J Clin Virol. 2013 Sep;58(1):318-20. doi: 10.1016/j.jcv.2013.04.024. Epub 2013 Jun 4.

PMID:
23756055
26.

Phenotypic and genotypic characterization of acyclovir-resistant corneal HSV-1 isolates from immunocompetent patients with recurrent herpetic keratitis.

Burrel S, Boutolleau D, Azar G, Doan S, Deback C, Cochereau I, Agut H, Gabison EE.

J Clin Virol. 2013 Sep;58(1):321-4. doi: 10.1016/j.jcv.2013.05.001. Epub 2013 May 31.

PMID:
23731845
27.

Detection of a new variant of herpes simplex virus type 2 among HIV-1-infected individuals.

Burrel S, Abrao EP, Désiré N, Seang S, Caumes E, Agut H, Boutolleau D.

J Clin Virol. 2013 Jul;57(3):267-9. doi: 10.1016/j.jcv.2013.03.008. Epub 2013 Apr 5. No abstract available.

PMID:
23567026
28.

Impact of novel mutations of herpes simplex virus 1 and 2 thymidine kinases on acyclovir phosphorylation activity.

Burrel S, Bonnafous P, Hubacek P, Agut H, Boutolleau D.

Antiviral Res. 2012 Dec;96(3):386-90. doi: 10.1016/j.antiviral.2012.09.016. Epub 2012 Oct 3.

PMID:
23041200
29.

Routine use of duplex real-time PCR assays including a commercial internal control for molecular diagnosis of opportunistic DNA virus infections.

Burrel S, Fovet C, Brunet C, Ovaguimian L, Hamm N, Conan F, Kalkias L, Agut H, Boutolleau D.

J Virol Methods. 2012 Oct;185(1):136-41. doi: 10.1016/j.jviromet.2012.05.031. Epub 2012 Jul 2.

PMID:
22766177
30.

Emergence of cytomegalovirus resistance to foscarnet in a patient receiving foscarnet salvage therapy for multidrug-resistant HIV infection.

Boutolleau D, Canestri A, Burrel S, Wirden M, Seang S, Clavel-Osorio C, Marcelin AG, Katlama C, Agut H.

J Clin Virol. 2012 Jun;54(2):194-6. doi: 10.1016/j.jcv.2012.02.008. Epub 2012 Mar 6.

PMID:
22398036
31.

Genotypic characterization of herpes simplex virus DNA polymerase UL42 processivity factor.

Burrel S, Aït-Arkoub Z, Agut H, Boutolleau D.

Antiviral Res. 2012 Jan;93(1):199-203. doi: 10.1016/j.antiviral.2011.10.016. Epub 2011 Oct 28.

PMID:
22061617
32.

Genotypic characterization of human cytomegalovirus UL97 phosphotransferase natural polymorphism in the era of ganciclovir and maribavir.

Boutolleau D, Burrel S, Agut H.

Antiviral Res. 2011 Jul;91(1):32-5. doi: 10.1016/j.antiviral.2011.04.015. Epub 2011 May 4.

PMID:
21570426
33.

Genotypic characterization of UL23 thymidine kinase and UL30 DNA polymerase of clinical isolates of herpes simplex virus: natural polymorphism and mutations associated with resistance to antivirals.

Burrel S, Deback C, Agut H, Boutolleau D.

Antimicrob Agents Chemother. 2010 Nov;54(11):4833-42. doi: 10.1128/AAC.00669-10. Epub 2010 Aug 23.

34.

[Persistent influenza virus infection in a patient treated with alemtuzumab].

Burrel S, Dilhuydy S, Bouabdallah K, Lafon MÉ, Milpied N, Fleury H.

Med Mal Infect. 2010 Nov;40(11):657-9. doi: 10.1016/j.medmal.2010.03.001. Epub 2010 Jul 16. French. No abstract available.

PMID:
20638206
35.

Prolonged shedding of influenza A(H1N1)v virus: two case reports from France 2009.

Fleury H, Burrel S, Balick Weber C, Hadrien R, Blanco P, Cazanave C, Dupon M.

Euro Surveill. 2009 Dec 10;14(49). pii: 19434.

36.

Supplemental Content

Loading ...
Support Center